Keros Therapeutics, Inc.
KROS
Revenue
3.04M
▲2.65M▲684.02%
3 Months ChangeAssets
615.89M
▲36.62M▲6.32%
3 Months ChangeLiabilities
44.33M
▼-2.10M▼-4.53%
3 Months ChangeFree Cash Flow
-45.51M
▼-10.21M▼-28.92%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-16
Form 8-K
ID: 0001664710-24-000081
2024-09-30
Form 8-K
ID: 0001664710-24-000078
2024-09-03
Form 8-K
ID: 0001664710-24-000075
2024-08-28
Form 8-K
ID: 0001664710-24-000072
2024-08-07
Form 8-K
ID: 0001664710-24-000069
2024-08-07
Form 10-Q
ID: 0001664710-24-000068
2024-08-07
Form 8-K
ID: 0001664710-24-000067
2024-06-17
Form 8-K
ID: 0001664710-24-000059
2024-06-17
Form 8-K
ID: 0001664710-24-000058
2024-06-17
Form 8-K
ID: 0001664710-24-000055